C-MER Medical 2026H1: Mainland Dental Profits Up 33%, Total Dental Revenue Up 19% to HK$282 Million

Source: C-MER Medical 2026 Interim Results Report

Mainland Dental Division Profit Up 33.2% / Mainland Ophthalmology Turns from Break-Even to Profitability / Total Dental Revenue Up 19.0%

DentalGoodNews｜August 25, 2026, C-MER Medical released its 2026 interim results report. The company achieved revenue of HK$1.024 billion (approximately RMB 885 million) in the first half of 2026, up 8.5% year-on-year; profit attributable to equity holders of the company for the period (Net Profit Attributable to Shareholders of the Parent Company) was HK$50.021 million (approximately RMB 43.251 million), up 0.2% year-on-year.

Source: C-MER Medical 2026 Interim Results Report

During the period, the company's mainland China business maintained growth. Among them, Shenzhen Aikangjian is a non-wholly-owned subsidiary in which the company holds a 61.5% stake, owning 1 dental hospital and 15 dental clinics as of June 30, 2026. Revenue from the mainland dental business segment increased 19.5% year-on-year to HK$259 million (approximately RMB 224 million), up 12.6% year-on-year in RMB terms; segment profit increased from HK$33.2 million (approximately RMB 28.706 million) in the first half of 2025 to HK$44.2 million (approximately RMB 38.218 million), up 33.2% year-on-year, while segment Gross Margin improved from 33.6% to 35.2%. The company attributed this primarily to increased revenue and improved coverage of fixed costs by revenue.

Source: C-MER Medical 2026 Interim Results Report

From a profitability perspective, gross profit from the mainland dental business increased from HK$72.9 million (approximately RMB 63.033 million) in the first half of 2025 to HK$91.19 million (approximately RMB 78.847 million) in the first half of 2026, up 25.0% year-on-year, with Gross Margin improving from 33.6% to 35.2%. The company stated that this improvement was mainly due to increased dental revenue and improved coverage of fixed costs by revenue. However, the company's selling expenses increased 20.7% year-on-year to HK$76.6 million (approximately RMB 66.232 million) during the same period, primarily due to increased promotional expenses for mainland dental services and Shenzhen Xiwa Aikangjian Hospital.

By comparison, C-MER Medical's full-year dental service revenue in 2025 was HK$507 million (approximately RMB 438 million), essentially flat compared with HK$507 million (approximately RMB 438 million) in 2024. In the first half of 2026, the company's overall dental service revenue had reached HK$282 million (approximately RMB 244 million), up 19.0% year-on-year; among which, mainland dental business revenue grew 19.5% and segment profit grew 33.2%, indicating that its mainland dental business achieved growth in the first half of 2026, accompanied by an improvement in segment Gross Margin.

Source: C-MER Medical 2026 Interim Results Report

By business nature (including Hong Kong dental clinics and mainland dental business), the company's overall dental service revenue increased 19.0% year-on-year to HK$282.5 million (approximately RMB 244 million), accounting for 27.6% of total revenue, higher than the 25.1% recorded in the same period of 2025. In terms of business scale, the total number of dental chairs increased 18.0% year-on-year to 328, and total patient visits increased 11.5% to 186,812; meanwhile, visits per dental chair decreased 5.5% year-on-year to 570, and revenue per dental chair increased only 0.8% to HK$861,000 (approximately RMB 744,000).

In terms of regional expansion, Shenzhen Aikangjian continued to expand its customer base and service scope at Luohu, Futian, and Liantang checkpoints. The Futian checkpoint flagship dental clinic, located only 200 meters from the border checkpoint, commenced operations in 2025 and demonstrated strong growth momentum in the first half of 2026; in addition, Shenzhen Aikangjian acquired a chain dental clinic at Liantang checkpoint in January 2025, and further expanded service capacity by establishing a new clinic at Liantang checkpoint, which began operations in 2025.